To examine this aspect, we subjected a cohort of 61 breast carcinoma biopsies of young women (age 19–45, median 37.1; Supplementary Table 1) to immunostaining applying anti-Hpa2 antibody. Here, HPSE2 is linked to breast carcinoma.